Question

Difficulty: HardPharmacokinetic and Pharmacodynamic Principles

A 39-year-old construction worker, maintained on chronic high-dose oral morphine therapy for severe lumbar radiculopathy, presents to the emergency department after sustaining a traumatic anterior shoulder dislocation. For pre-procedural analgesia prior to joint reduction, the attending physician administers a standard intravenous dose of buprenorphine. Within fifteen minutes, the patient begins exhibiting profound diaphoresis, mydriasis, piloerection, and intense psychomotor agitation. Vital signs reveal a heart rate of 128/min and blood pressure of 168/98 mmHg. Which of the following pharmacologic principles best explains the mechanism underlying this patient's acute clinical deterioration?

  1. The administered agent has a lower dissociation constant (KdK_d) and a lower maximal efficacy (EmaxE_{max}) than the maintenance medication.Answer
  2. B
    The administered agent has a higher dissociation constant (KdK_d) and an equivalent maximal efficacy (EmaxE_{max}) compared to the maintenance medication.
  3. C
    The administered agent acts as a noncompetitive antagonist, lowering the maximal efficacy (EmaxE_{max}) without altering the dissociation constant (KdK_d).
  4. D
    The administered agent rapidly induces hepatic biotransformation, increasing the elimination rate constant (kek_e) of the maintenance medication.
  5. E
    The administered agent competitively inhibits cytochrome P450 enzymes, resulting in a sudden increase in the steady-state plasma concentration (CssC_{ss}) of the maintenance medication.

Answer

The administered analgesic displaces the home medication because it has a higher receptor affinity (a lower dissociation constant, KdK_d) but precipitates withdrawal because it produces a weaker biological response (a lower maximal efficacy, EmaxE_{max}).
The correct answer identifies that the administered drug (buprenorphine) displaces the maintenance drug (morphine) because it binds more tightly to the receptor, reflected by a lower dissociation constant (KdK_d). However, because it is only a partial agonist, it cannot fully activate the receptor, meaning it has a lower maximal efficacy (EmaxE_{max}). In an opioid-dependent patient, this sudden replacement of a high-efficacy drug with a low-efficacy drug causes a massive net drop in mu-opioid receptor signaling, instantly precipitating withdrawal.

Step-by-Step Solution

1
Analyze the patient's clinical presentation.
The sudden onset of diaphoresis, mydriasis, piloerection, tachycardia, and agitation in a patient dependent on high-dose morphine represents acute opioid withdrawal.
Recognizing the syndrome is required to determine the mechanism of the adverse drug event.
2
Identify the pharmacological properties of the administered drug.
Buprenorphine was administered. Buprenorphine is a partial mu-opioid agonist, meaning it binds strongly to the receptor but activates it only partially.
Understanding the drug class allows translation into specific pharmacokinetic and pharmacodynamic parameters.
3
Translate the drug properties into pharmacodynamic variables.
High binding affinity correlates with a low dissociation constant (KdK_d). Partial activation correlates with a low maximal efficacy (EmaxE_{max}) compared to a full agonist like morphine.
The correct answer must describe how buprenorphine displaces morphine (low KdK_d) while providing inadequate opioid stimulation to prevent withdrawal (low EmaxE_{max}).

Key Concept

Buprenorphine is a partial mu-opioid agonist with a lower dissociation constant (KdK_d, indicating higher affinity) and a lower maximum efficacy (EmaxE_{max}) than full agonists like morphine, allowing it to precipitate withdrawal in opioid-dependent patients.
Rate this question